Expression and clinical significance of family with sequence similarity 96 member B in hepatocellular carcinoma
张智勇,金炜东,张建新,刘志苏,马丹丹,张杨
DOI: https://doi.org/10.3760/cma.j.cn421213-20200527-01179
2021-01-01
Abstract:Objective:To investigate the expression of family with sequence similarity 96 member B (FAM96B) in hepatocellular carcinoma (HCC) tissues and paired adjacent non-tumor tissues, and its clinical significance.Methods:Tissue specimens and clinical data of HCC patients who received surgical treatment in the Central Theater Hospital between January 2012 and December 2013 were collected. Immunohistochemistry (IHC) and Western blotting were used to examine the expression and distribution of FAM96B in 96 cases of HCC tissues and paired adjacent tieeues. In addition, the correlation between the expression of FAM96B and clinicopathological features and prognosis of HCC was analyzed. Statistical analysis was performed using SPSS 21.0. The measurement data were expressed as mean±standard deviation. The mean comparison between the two groups was performed by t test. Chi-square test was used to compare the rates. The survival curve and survival rate were respectively drawn and calculated by the Kaplan-Meier method. The univariate analysis and multivariate analysis were done using the COX regression model. Results:IHC showed that the positive expression rate of FAM96B in adjacent non-tumor tissues was significantly higher than that in tumor tissues [72.9% (70/96) vs. 37.5% (36/96) ( χ2=12.174, P<0.01). Western blotting showed that FAM96B protein expression level was significantly lower in tumor tissues than in adjacent non-tumor tissues (0.703±0.136 vs. 1.617±0.248, t=31.733, P<0.01). Moreover, the expression difference of FAM96B was correlated with tumor diameter ( t=8.575, P<0.01), alpha fetal protein (AFP, t=7.828, P<0.01), vascular tumor thrombus ( t=-6.836, P<0.01), HCC differentiation grade ( t=6.892, P<0.01), and not with sex ( t=0.119, P>0.05), age ( t=0.073, P>0.05), hepatitis B antigen ( t=-1.920, P>0.05), hepatocirrhosis ( t=-1.508, P>0.05). Results of univariate analysis showed that tumor diameter ( χ2=7.458, P<0.05), AFP ( χ2=32.993, P<0.05), vascular tumor thrombus ( χ2=35.764, P<0.05), HCC differentiation grade ( χ2=5.041, P<0.05) and FAM96B protein expression level ( χ2=3.937, P<0.05) were related factors affecting overall survival of HCC patients. The overall survival of the HCC patients with high FAM96B expression was significantly longer than that of patients with low FAM96B expression (median survival time 38 months vs. 24 months, χ2=3.937, P<0.05). Results of multivariate analysis showed that tumor diameter [hazard ratio ( HR) =0.304, 95% confidence interval ( CI) : 0.121-0.764, P<0.05], AFP ( HR=0.366, 95% CI: 0.142-0.943, P<0.05), vascular tumor thrombus ( HR=0.453, 95% CI: 0.228-0.903, P<0.05) and FAM96B protein level ( HR=4.625, 95% CI: 1.654-13.003, P<0.05) were independent factors affecting overall survival of HCC patients. Conclusion:The tumor diameter, AFP, vascular tumor thrombus and FAM96B expression level are independent factors affecting long-term survival of HCC patients. Moreover, FAM96B expression level is associated with the malignant degree and poor prognosis of HCC.